You have no items in your shopping cart.
Recombinant Mouse CD86/B7-2 Protein, His Tag
Description
Images & Validation
−
Key Properties
−| Source | Recombinant Mouse CD86/B7-2 Protein is produced by HEK293 Cells expression system. The target protein is expressed with sequence (Val24-Glu245) of mouse CD86/B7-2 (Accession #NP_062261.3) fused with a 6��His Tag at the C-terminus. |
|---|---|
| Expression System | HEK293 Cells |
| Target | CD86 |
| Reactivity | Mouse |
| Purity | > 97% by SDS-PAGE. |
| Endotoxins | > 97% by SDS-PAGE. |
Storage & Handling
−| Disclaimer | For research use only |
|---|
Alternative Names
−Similar Products
−Human B7-2 Protein, mFc-His Tag [orb689395]
The purity of the protein is greater than 95% as determined by SDS-PAGE and Coomassie blue staining.
The protein has a predicted molecular mass of 52.4 kDa after removal of the signal peptide.
Mammalian
100 μg, 10 μg, 50 μgRecombinant Mouse CD86/B7-2 Protein, Fc His Tag [orb1551110]
> 97% by SDS-PAGE.
Recombinant Mouse CD86/B7-2 Protein is produced by HEK293 Cells expression system. The target protein is expressed with sequence (Val24-Glu245) of mouse CD86/B7-2 (Accession #NP_062261.3) fused with a Fc tag at the C-terminus.
100 μg, 50 μgRecombinant Mouse CD86/B7-2 Protein, N-His [orb2831475]
>90% as determined by SDS-PAGE.
26.03 kDa
100 μg, 20 μg, 50 μg

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.
Quick Database Links
Documents Download
Request a Document
Protocol Information
Recombinant Mouse CD86/B7-2 Protein, His Tag (orb1551107)
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review


